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Objective: Total joint arthroplasty (TJA) outcome studies have largely focused on recipients of a single
primary TJA, which may bias outcome estimates.
Design: This retrospective cohort study utilized health administrative databases from Ontario, Canada, to
assemble a cohort that received a ﬁrst primary elective hip or knee TJA for osteoarthritis (OA) between
2002 and 2009 (index TJA). Characteristics of TJA recipients at their index TJA were compared for those
who did vs did not go on to receive one or more subsequent primary, elective hip/knee TJAs (multiple
TJAs e yes/no) over a 2-year follow-up period. Cox proportional hazards, censored on death, was used to
examine the relationship of receipt of multiple TJAs (yes/no) on rates of surgical complications for the
index TJA, controlling for confounders.
Results: Among 97,374 eligible patients, 19,856 (20.4%) received a second primary elective TJA procedure
within 2 years. In bivariate analyses, recipients of multiple primary TJAs were signiﬁcantly more likely
than single TJA recipients to be female, younger, with fewer co-morbidities (P < 0.0001), and to expe-
rience surgical complications with the index surgery, including early revision (P < 0.0001). Controlling
for patient differences, receipt of >1 primary TJAs over 2 years was independently and signiﬁcantly
associated with lower odds of having experienced a surgical complication following the index arthroplasty
(adjusted HR 0.65, 95%CI 0.59e0.72).
Conclusions: One in ﬁve patients receiving their ﬁrst elective primary hip or knee TJA received a second
hip/knee TJA within 2 years. Our results indicate that exclusion of this large subsample of TJA recipients
from TJA outcomes studies over-estimates surgical risks and may underestimate patient-reported
beneﬁts.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Background
Total joint arthroplasty (TJA) is the cornerstone of treatment for
end-stage osteoarthritis (OA) of the hip or knee, a stage deﬁned by
unacceptable levels of pain and physical dysfunction despite
appropriate medical management. Primary arthroplasty of the hip
(THA) and knee (TKA) are, on average, effective in providing pain. Ravi, 76 Grenville Street, 8th
1-416-323-7722.
eshma.ravi@mail.utoronto.ca
ker@utoronto.ca (G. Hawker).
s Research Society International. Prelief and improvement in joint functioning and health-related
quality of life1e7. However, substantial variability in TJA outcomes
has been documented, with 15e30% of TJA recipients reporting
suboptimal outcomes3,4,8e10. These ﬁndings are largely based on
outcomes of cohorts receiving a single primary, elective TJA. When
analyzing the impact of an initial TJA, these studies have typically
excluded individuals who received another primary elective joint
replacement during the follow-up period of the index TJA10e17.
Reasons cited include: difﬁculty discriminating the effects of
sequential surgeries on the costs, patient-reported outcomes, and
complication rates (including revision arthroplasty) of the index
TJA, and the inability to discriminate subsequent revision of the
index TJA from a second primary TJA procedure using International
Classiﬁcation of Diseases Volume 9 (ICD9) procedure codes18e21.ublished by Elsevier Ltd. All rights reserved.
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undergo sequential primary TJA procedures from TJA outcomes
studies may systematically bias the results. Compared with re-
cipients of a single TJA, those who receive multiple primary TJAs
may have a greater overall burden of OA, with multiple hips and
knees involved. As the latter has been shown to negatively inﬂu-
ence patient-reported TJA outcomes22e24, excluding these in-
dividuals may overestimate the beneﬁts of TJA. Alternatively,
individuals who undergo a second primary TJA following an index
procedure may be systematically happier with the results of the
index procedure, with better patient-reported outcomes and/or
fewer surgical complications, than those who do not. If so, the
exclusion of their initial procedure from TJA outcome studies would
underestimate the beneﬁts of TJA. Finally, as patients with
advanced OA typically have more than one hip and/or knee
requiring TJA22e24, results of studies that exclude recipients ofmore
than one primary elective TJA may lack generalizability.
As the demand for TJA increases, clarifying the determinants of a
‘good TJA outcome’ is increasingly important25,26. Identifying these
predictors aids patient-physician decision-making around appro-
priateness for primary arthroplasty27. It is critical that decisions
about appropriateness are evidence-based. Thus, the extent to
which results based on recipients of a single, primary, elective TJA
can be generalized to those who receive sequential primary TJAs
warrants evaluation.
Objectives
The objectives of the current study were to: (1) determine the
proportion of ﬁrst-time TJA recipients that go on to have a second
TJA within 2 years; and (2) compare the characteristics, at the
time of the index TJA, of individuals who did vs did not receive a
subsequent primary, elective hip/knee TJAs (multiple TJAs e yes/
no) during a 2-year follow-up from the index TJA and determine,
after controlling for any differences observed, whether or not the
rate of surgical complications for the index TJA differed for the two
groups.
Methods
Study design
Retrospective cohort study.
Setting and participants
Residents of Ontario have universal public health insurance
covering all medically necessary services. Service details, across
the full spectrum of patients and providers are documented in
health administrative databases that can be linked on an indi-
vidual basis to provide a complete health services history. We
identiﬁed Ontario residents that underwent a primary TJA of the
hip or knee in any Ontario hospital between April, 2002 and
March, 2009. We excluded those who had received a primary or
revision TJA prior to April 1, 2002, those whose ﬁrst procedure was
non-elective (e.g., for cancer, fracture, or external cause of injury),
and those with a diagnosis of inﬂammatory arthritis. We also
excluded individuals who underwent bilateral TJA during the in-
dex admission as bilateral procedures (particularly knee re-
placements) during the same hospitalization have been associated
with higher rates of early surgical complications compared with
unilateral primary TJA28. Finally, we excluded patients who died
within 2 years of the index arthroplasty to avoid differential
follow-up and immortal time bias.Variables
Among individuals who received their ﬁrst primary elective hip/
knee TJA for OA between 2002 and 2009, we determined de-
mographic characteristics (age, proportion of females, income
quintile, rurality) and co-morbidity at the time of the index pro-
cedure from the Registered Persons Database (RPDB). The presence
of speciﬁc co-morbidities (chronic obstructive pulmonary disease,
congestive heart failure, baseline cardiovascular disease risk, dia-
betes and hypertension) were identiﬁed by validated criteria using
hospital discharge abstracts29e31 and a look back period of 2 years.
In addition, co-morbidity at the index admission was summarized
using a validated adaptation of the Charlson co-morbidity Index for
arthroplasty recipients20,32. We also determined, for the index
procedure, length of hospital stay and hospital type (teaching
hospital e yes/no) from the hospital discharge abstracts.
TJA recipients were followed forward from the date of the index
procedure for 2 years to determine the occurrence of one or more
subsequent TJA procedures, including elective primary hips and
knees. Using this information, TJA recipients were categorized as
having received a single primary elective hip/knee TJA (the index
procedure) or more than one (i.e., multiple) primary elective hip/
knee TJA procedures during the follow-up period. The outcomes of
interest were the occurrence, for the index TJA procedure, of the
following complications: acute myocardial infarction (AMI), deep
vein thrombosis (DVT), or pulmonary embolism (PE) within
90 days; or dislocation or revision of the index arthroplasty within
2 years of the date of surgery.Data sources
The main data sources for this retrospective cohort study were
hospital discharge abstracts from the Canadian Institute for
Health Information Discharge Abstract Database (CIHI-DAD),
physician billings from the Ontario Health Insurance Plan (OHIP),
and the RPDB which provides basic demographic information.
These data sets were held securely in a linked, de-identiﬁed form
and analyzed at the Institute for Clinical Evaluative Sciences. We
identiﬁed THA and TKA recipients using speciﬁc International
Classiﬁcation of Diseases, Canadian Classiﬁcation of Health In-
terventions (ICD-10-CA/CCI) procedure and diagnostic codes
(Appendix 1). Revisions were identiﬁed using ICD-10-CA/CCI
procedure codes for TJA accompanied by the supplementary
status attribute “R.” CCI codes for interventions also include a
‘location’ code that identiﬁes the laterality of the procedure (right,
left, or bilateral), so that revisions and dislocations can be linked
speciﬁcally to the index TJA or to a subsequent TJA. The other
complications were identiﬁed using the appropriate ICD-10
diagnostic codes (Appendix 1).Statistical analysis
The characteristics at their index TJA of single vs multiple pri-
mary, elective TJA recipients were compared using t-tests for nor-
mally distributed variables. Wilcoxon rank-sum tests were used for
skewed variables and Chi-square or Fisher exact tests for categor-
ical variables. Cox proportional hazards regression models,
censored on death and accounting for clustering of patients within
surgeons, were used to estimate the hazard of the occurrence of our
composite complication outcome following the index TJA for single
vs multiple TJA recipients, before and after controlling for cova-
riates. Covariates controlled for included known predictors of TJA
complications and factors that might clinically determine the
likelihood of receiving more than one TJA procedure based on
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9.1 for UNIX (SAS Institute).
Results
Cohort characteristics
Between April 1, 2002 and March 31, 2009, there were 169,356
recipients of at least one primary elective TJA (69,974 THA; 99,382
TKA). Of these, 70,769 (41.7%) were excluded due to occurrence of a
pre-baseline arthroplasty, pre-existing joint infection, fracture or
cancer, or a diagnosis of inﬂammatory arthritis (Table I). A further
1,213 patients (0.7%) who died within 2 years of the index TJAwere
also excluded. Our ﬁnal cohort included 97,374 index primary
elective TJA recipients (37,670 THAs and 59,704 TKAs).
Patterns of TJA procedures within 2 years of the index TJA procedure
In the 2 years following the index TJA procedure, 24.5% of index
TKA recipients and 16.7% of index THA recipients received a second
TJA procedure. For 95% of these individuals, the second procedure
was a primary elective TJA on another hip or knee (Table II), giving
20,140 multiple and 78,762 single primary elective TJA recipients.
For those who received a second primary, elective hip/knee TJA, the
median time to the second arthroplasty was 438 days (inter-quar-
tile range: 231e979 days).
Characteristics at the index TJA procedure of multiple vs single
primary elective TJA recipients
At their index TJA procedure, those who went on to one or more
subsequent TJAs were more likely than those who did not to be
female (60.5% vs 57.2%, P < 0.0001), younger (mean age 66.6 vs
67.1 years, P< 0.0001), to have less co-morbidity (Charlson score of
2þ: 3.7% vs 4.3%, P < 0.0001) and to have received an index knee
TJA (70% vs 59%, P < 0.0001); their index TJA length of stay was
shorter (4.7 vs 4.9 days, P ¼ 0.0011), they were less likely to receive
their index TJA at a teaching hospital (28.6% vs 30.6%, P < 0.0001)
(Table III), and their likelihood of experiencing our composite TJA
complication outcome following the index TJA was lower (2.4% vs
3.8%, P < 0.0001) (Table III).
Results of univariate and multivariate hazards regression
In univariate analyses, a higher likelihood of experiencing one or
more of our surgical complications following the index TJA was
associated with: older age (unadjusted HR 0.99, 95%CI 0.98e0.99,
P ¼ 0.001), male sex (unadjusted HR 1.12, 95%CI 1.03e1.23,Table I
Study sample
Num
Hip
Inclusion
1 primary TJA between April 1, 2002 and Mar 31, 2009 69,97
Exclusion
Received a primary or revision TJA before March, 2002 14,53
Pre-existing joint infection, cancer, deformity, fracture,
or non-elective procedure
7,892
2 TJA procedure at index admission 2,819
No information on laterality of index procedure 38 (0
Did not meet OHIP eligibility criteria (<2 years look back) 319 (
Not performed by an Orthopaedic surgeon 3 (0.0
Diagnosis of inﬂammatory arthritis 6,155
Died within 2 years of index procedure 541 (
Final cohort 37,67P ¼ 0.01), and greater co-morbidity (Charlson score 1 vs 0: unad-
justed HR 1.32, 95%CI 1.10e1.59, P ¼ 0.003; Charlson score of 2 or
more vs 0: unadjusted HR 1.33, 1.10, 1.62, P¼ 0.005). Controlling for
these factors, individuals who went on to receive additional TJAs
were independently and signiﬁcantly less likely to have experi-
enced a surgical complication following the index TJA than those
who did not (adjusted HR 0.47, 95%CI 0.41e0.54, P < 0.0001)
(Table IV). Stratiﬁed by index joint replaced, we found this associ-
ation was stronger for index TKA than THA recipients (TKA:
adjusted HR 0.37, 95%CI 0.32e0.47, P < 0.0001; THA: 0.69, 95%CI
0.59e0.80, P ¼ 0.0003).
Discussion
In a population cohort undergoing a ﬁrst primary, elective hip or
knee TJA, one in ﬁve TJA recipients received a second primary
elective TJA within 2 years of the index procedure. Individuals who
received more than one primary elective TJA during the follow-up
period differed from those who did not in being, on average,
healthier at the time of the index TJA, and were less likely to have
experienced a surgical complication related to the index procedure.
Collectively, these results suggest that the routine exclusion of this
substantial subgroup of patients from TJA outcomes studies results
in systematic overestimation of the overall rates of surgical
complications.
For those individuals who received a second primary, elective
TJA during the follow-up period, the most common subsequent
procedure was an elective primary TJA of the contralateral hip or
knee. This is consistent with our current understanding of the poly-
articular nature of OA, and the high prevalence of concomitant
involvement of other hips and knees amongmany TJA recipients22e
24. For patients with more than one symptomatic hip or knee,
multiple TJA procedures, e.g., planned sequential and/or bilateral
procedures, may be required in order to achieve maximal
improvement in both pain and functioning. If so, evaluating pain
and functional outcomes following the ﬁrst of multiple planned
procedures may be premature, resulting in under-estimates of the
overall patient beneﬁt associated with TJA. Further studies are
needed to examine the inﬂuence of multiple primary procedures in
such patients on achievement of good functional outcomes.
There are several methodologic arguments against excluding
patients who receive multiple primary TJAs over a study period.
Firstly, excluding patients for factors or events that are not apparent
at baseline leads to time-dependent bias and raises concerns about
reverse causality. In time-to-event analyses, time-dependent bias
will tend to exaggerate the relationship between an exposure and
an outcome33. Reverse causality can occur when the outcome of
interest is causally related to the exposure being studied34,35. Ifber of patients
Knee Total
4 99,382 169,356
7 (20.8%) 17,670 (17.8%) 32,207 (19.0%)
(11.3%) 1,353 (1.4%) 9,245 (5.5%)
(4.0%) 6,991 (7.0%) 9,810 (5.8%)
.1%) 44 (0.04%) 82 (0.05%)
0.8%) 592 (0.6%) 911 (0.5%)
1%) 1 (0.001%) 4 (0.002%)
(8.8%) 12,355 (12.4%) 18,510 (10.9%)
0.8%) 672 (0.7%) 1,213 (0.7%)
0 59,704 97,374
Table II
Occurrence of subsequent TJA procedures over 2 years following the index primary, elective TJA
Primary TKA Primary THA Both THA & TKA
Number of index procedures N ¼ 59,704 N ¼ 37,670 N ¼ 97,374
Number who went on to subsequent procedure 14,671 (24.5%) 6,309 (16.7%) 20,980 (21.5%)
Type of subsequent procedure
e Revision of index 705 (1.2%) 419 (1.1%) 1,124 (1.2%)
e Contralateral elective primary 12,950 (21.7%) 4,571 (12.1%) 17,521 (18%)
e Elective primary of another hip or knee 1,016 (1.7%) 1,319 (3.5%) 2,335 (2.4%)
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lack of complications after their ﬁrst TJA, then their exclusion
would artiﬁcially inﬂate the risk of complications in patients who
only received a single TJA. Exclusion of patients for factors that are
not readily apparent at baseline, or which occur after the event
being studied, precludes the formation of predictive tools derived
from regression analyses.
Our results suggest that recipients of a single vs multiple TJAs
may also have experienced worse patient-reported outcomes
following their index TJA procedure. The former were older, more
likely to be female and of lower socioeconomic status. These factors
are associated with worse hip/knee OA severity36e39, which has is
the strongest predictor of post-operative pain and func-
tioning1,10,11,40,41. Further, controlling for these differences, in-
dividuals who underwent only one vs more than one primary TJAs
were more likely to have experienced a surgical complicationTable III
Characteristics of the TJA recipients at the index TJA procedure
All primary TJA recipients
Number of patients 97,374
Demographics
Age (y) [mean (SD)] 67.0 (10.6)
Sex [N (%)]
Male 40,927 (42.1%)
Female 56,303 (57.9%)
Income quintile [N (%)]
Lowest 16,564 (17.1%)
2 19,427 (20.0%)
3 19,360 (19.9%)
4 20,173 (20.8%)
Highest 21,531 (22.2%)
Rurality index (out of 100, 0 ¼ least rural) 13.6 (18.8)
Index procedure
THA [N (%)] 37,670 (38.7%)
TKA [N (%)] 59,704 (61.3%)
Co-morbidities
Baseline CVD risk [N (%)] 6,108 (6.3%)
Diabetes [N (%)] 19,721 (19.8%)
HTN [N (%)] 64,493 (66.2%)
COPD [N (%)] 16,430 (16.9%)
CHF [N (%)] 4,963 (5.1%)
Charlson score [N (%)]
0 88,749 (91.1%)
1 4,556 (4.7%)
2 or more 4,069 (4.2%)
Complications
DVT within 90 days [N (%)] 947 (1%)
PE within 90 days [N (%)] 610 (0.6%)
AMI within 90 days [N (%)] 626 (0.6%)
2 years infection [N (%)] 570 (0.6%)
2 years revision [N (%)] 1,124 (1.2%)
Occurrence of any of the complications
(listed above) [N (%)]
3,412 (3.5%)
Admission characteristics
Length of stay (d) [mean (SD)] 4.9 (3.3)
Index procedure at teaching hospital [N (%)] 27,407 (30.2%)
CVD: cardiovascular disease; HTN: hypertension; COPD: chronic obstructive pulmonary
* Comparison of ‘single’ with ‘multiple’ TJA group.following the index TJA. Surgical complications have also been
associated with worse patient-reported TJA outcomes and lower
likelihood of patient satisfactionwith their surgical results10,13,42,43.
Further research is warranted.
The retrospective nature of our study, and reliance on admin-
istrative data, precluded our ability to determine whether some of
the individuals who underwent a single primary TJAwere intended
to undergo sequential procedures, but the higher rate of compli-
cations and/or poorer patient-reported outcomes led to shifts in
patient or surgeon willingness to proceed with another TJA or that
sequential TJA procedures are more likely to be offered a priori to
those with the lowest risks for surgical complications. Prospective
studies are required to elucidate these relationships and to clarify
the extent of confounding by indication, whereby patients who are
healthier and with an uncomplicated post-operative course are
more likely to have a second TJA (if one is indicated). If, as weWent on to receive another primary,
elective TJA procedure within 2 years
P-value*
No Yes
77,518 (79.6%) 19,856 (20.4%)
67.1 (10.8) 66.6 (9.8) P < 0.0001
P < 0.0001
33,100 (42.8%) 7,827 (39.5%)
44,312 (57.2%) 11,991 (60.5%)
P < 0.0001
13,249 (17.2%) 3,315 (16.7%)
15,325 (19.8%) 4,102 (20.7%)
15,307 (19.8%) 4,053 (20.5%)
16,024 (20.7%) 4,149 (20.9%)
17,344 (22.5%) 4,187 (21.1%)
13.5 (18.8) 14.0 (19.1) P < 0.0001
P < 0.0001
31,780 (41.0%) 5,890 (29.7%)
45,738 (59%) 13,966 (70.3%)
4,976 (6.4%) 1,132 (5.7%) P ¼ 0.0002
15,176 (19.6%) 4,095 (20.6%) P ¼ 0.0010
50,657 (65.4%) 13,836 (69.7%) P < 0.0001
13,258 (17.1%) 3,172 (16%) P ¼ 0.0002
4,035 (5.2%) 928 (4.7%) P ¼ 0.0024
P < 0.0001
70,475 (90.9%) 18,274 (92.0%)
3,711 (4.8%) 845 (4.3%)
3,332 (4.3%) 737 (3.7%)
794 (1%) 153 (0.8%) P ¼ 0.0012
520 (0.7%) 90 (0.5%) P ¼ 0.0005
576 (0.7%) 50 (0.3%) P < 0.0001
455 (0.6%) 115 (0.6%) P ¼ 0.8978
1,001 (1.3%) 123 (0.6%) P < 0.0001
2,929 (3.8%) 483 (2.4%) P < 0.0001
4.9 (3.5) 4.7 (2.4) P ¼ 0.0011
23,729 (30.6%) 5,678 (28.6%) P < 0.0001
disease; CHF: congestive heart failure.
Table IV
Factors associated with occurrence of any complication* following elective primary
TJA
Factor Unadjusted HR
(95%CI)
Adjusted HR
(95%CI)
P-value
Age (y) 0.99 (0.98, 0.99) 0.99 (0.99, 0.99) 0.001
Male sex 1.12 (1.03, 1.23) 1.07 (0.98, 1.17) 0.15
Income quintile
Lowest 1.11 (0.97, 1.28) 1.13 (0.98, 1.30) 0.10
2 1.03 (0.89, 1.18) 1.05 (0.91, 1.21) 0.49
3 1.03 (0.89, 1.18) 1.04 (0.91, 1.20) 0.55
4 1.11 (0.97, 1.27) 1.12 (0.98, 1.27) 0.11
Highest Ref Ref
Charlson score
0 Ref Ref
1 1.32 (1.10, 1.59) 1.32 (1.09, 1.59) 0.004
2þ 1.33 (1.09, 1.62) 1.33 (1.09, 1.62) 0.005
Teaching hospital 0.93 (.85, 1.01) 0.89 (0.81, 0.99) 0.03
Index procedure
THA 1.34 (1.24, 1.46) 1.30 (1.19, 1.43) <0.0001
TKA Ref Ref
Went on to receive
another elective
primary TJA within
2 years of the index
procedure
0.45 (0.39, 0.51) 0.47 (0.41, 0.54) <0.0001
* Any complication: occurrence of any of the following complications in the
90 days following surgery (DVT, PE, AMI), OR occurrence of infection or revision in
the 2 years following surgery.
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satisﬁed with their index surgery’s outcomes, excluding these in-
dividuals from TJA outcomes studies may explain, in part, the re-
ported ‘unsuccessful’ TJA results in up to 30% of primary TJA
recipients3,4,8,44.
Our results support the inclusion of patients who receive more
than one primary elective TJA, in studies evaluating the outcome(s)
of these procedures. The optimal statistical methodology by which
to incorporate multiple procedures, and their associated outcomes
is less clear, and may differ depending on the outcome of interest.
For example, multilevel modelling may be required to account for
the correlation within patients and within surgeons. Studies which
evaluate changes in symptoms or health-related quality of life may
need to adequately assess patients pre-operatively to determine
the extent of their arthritis burden, and the number of joints which
may require replacement. It may be more appropriate to compare
patients with similar burdens, and determining predictors of suc-
cess or failure in these speciﬁc subgroups. Arthroplasty registers do
not typically exclude patients with multiple primary elective
arthroplasties. However, these data sources have a few important
limitations: (1) these registries are often split by the joint being
replaced, and do not always record data on subsequent TJAs on
different joints; and (2) the unit of assessment in these registries is
the procedure (a THA or TKA), not the individual on whom the
procedure is being performed. Research is needed to evaluate and
compare alternate approaches to addressing these questions, and
thus to guide future TJA outcomes research.
Strengths of our study include its population base, very large
sample size, and the use of validated algorithms for deﬁning co-
morbidity and surgical complications using health administrative
data29e31. However, therewere also some limitations, in addition to
those noted above. First, our large sample provided substantial
statistical power to discern for TJA group differences, some of the
differences were very small, and possibly not clinically meaningful
(e.g., age). Second, we excluded individuals who received bilateral
procedures during their index admission, as there is some evidence
to suggest these individuals have higher rates of early surgical
complications28. Bilateral primary elective TJAs occurred in 4% ofhip and 7% of knee TJA admissions. Future studies are needed to
elucidate whether these individuals are more or less similar to
those who experience a single or multiple sequential procedures.
We also excluded patients who died within 2 years of the index
procedure to avoid immortal time bias45. This resulted in exclusion
of only 0.7% of all TJA recipients. Thus, we believe this exclusion is
unlikely to have had a substantial impact on our results. Third, we
did not have information on several potential confounders,
including each patient’s body-mass index (BMI). Patients with
increased BMI are more likely to have bilateral knee OA and thus
require more than one TKA. Obesity may also increase risk for
surgical complications e therefore studies that exclude patients
who go on to have a subsequent TJA may result in older, sicker and
obese patients being overrepresented in the sample. Finally, we
limited our study to patients with OA, the condition that is
responsible for the majority of TJA procedures46,47. Thus, our ﬁnd-
ings may not be generalizable to individuals with other conditions,
such as inﬂammatory arthritis.
In conclusion, in a large population undergoing a ﬁrst primary
elective hip or knee replacement, one in ﬁve TJA recipients expe-
rienced a second primary, elective joint replacement during the
2 years following the index procedure. Individuals who experi-
enced more than one primary TJA procedures during the 2 year
study period were healthier and less likely to have experienced a
complication at their index TJA. These ﬁndings suggest that the
routine exclusion of this large group leads to over-estimates of the
risks of TJA, and possibly under-estimates of the overall beneﬁts to
the patient.
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Appendix 1
Codes used to identify TJAs
OHIP (with FEESUFF ¼ ‘A’)
B. Ravi et al. / Osteoarthritis and Cartilage 21 (2013) 1841e18481846HIP
THA e Primary
R440 Total hip replacement e acetabulum and femur THA e
Revision
R241Revision total arthroplasty hipe one or both componentse
acetabular or femoral
KNEE
TKA e Primary
R441 Total replacement/both compartments R248 Total knee
replacement with take down of fusion TKA e Revision
R244 Revision total arthroplasty knee
DAD
THA e Primary
Prior to 2002 (ICD9/CCP)e For look back [variable PRCODE1-10].
 93.51, total hip replacement with methyl methacrylate; and
93.59, other total hip replacement.
April 1, 2002eMarch31, 2010 (ICD10/CCI) [variable INCODE1-20].
 1.VA.53, implantation of internal device, hip joint – 1.VA.53.LA-
PN (open approach) and 1.VA.53.PN-PN (robotics-assisted
approach)
THA e Revision
 Prior to 2002 (ICD9/CCP) e For look back
 93.52, revision cemented with methyl methacrylate; and 93.53,
revision uncemented.
April 1, 2002eMarch 31, 2010 (ICD10/CCI)
 As for Primary, but with Status Attribute ¼ R [variable INAT-
STAT1-20].
TKA e Primary
Prior to 2002 (ICD9/CCP) e For look back
 93.41, geomedic and polycentric total knee replacement
April 1, 2002eMarch 31, 2010 (ICD10/CCI)
 1.VG.53, implantation of internal device, knee joint (includes
both TKAs and partial knee replacements (single component
prosthetic devices and cement spacers to maintain consistency
with above))
TKA e Revision
Prior to 2002 (ICD9/CCP) e For look back
 93.40, revision of total knee replacement cemented or
uncemented
April 1, 2002eMarch 31, 2010 (ICD10/CCI)
 As for Primary, but with Status Attribute ¼ R [variable INAT-
STAT1-20].
Diagnosis codes for complications
DVT
I801, Phlebitis and thrombophlebitis of femoral vein
I802, Phlebitis and thrombophlebitis of other deep vessels of
lower extremities
I803, Phlebitis and thrombophlebitis of lower extremities,
unspeciﬁed
I809, Phlebitis and thrombophlebitis of unspeciﬁed site
I822, Embolism and thrombosis of vena cava
I823, Embolism and thrombosis of renal vein
I828, Embolism and thrombosis of other speciﬁed veins
I829, Embolism and thrombosis of unspeciﬁed vein
PE
I260, Pulmonary embolism with mention of acute cor
pulmonale
I269, Pulmonary embolism without mention of acute cor
pulmonaleAMI
I210, Acute transmural myocardial infarction of anterior wall
I211, Acute transmural myocardial infarction of inferior wall
I212, Acute transmural myocardial infarction of other sites
I213, Acute transmural myocardial infarction of unspeciﬁed site
I2140, Acute subendocardial myocardial infarction of anterior
wall
I2141, Acute subendocardial myocardial infarction of inferior
wall
I2142, Acute subendocardial myocardial infarction of other sites
I2149, Acute subendocardial myocardial infarction, unspeciﬁed
site
I219, Acute myocardial infarction, unspeciﬁed
I220, Subsequent myocardial infarction of anterior wall
I221, Subsequent myocardial infarction of inferior wall
I228, Subsequent myocardial infarction of other sites
I229, Subsequent myocardial infarction of unspeciﬁed site
Dislocation
OHIP
D042, D043, R628, D038, D039, D040, D031, R403
ICD10
S730x, x ¼ 0,1,8,9; S8310x, x ¼ 0,1,2,3,8,9; S83000 or S83001
S73000, Posterior dislocation of hip, closed
S73001, Posterior dislocation of hip, open
S73010, Obturator dislocation of hip, closed
S73011, Obturator dislocation of hip, open
S73080, Other anterior dislocation of hip, closed
S73081, Other anterior dislocation of hip, open
S73090, Unspeciﬁed dislocation of hip, closed
S73091, Unspeciﬁed dislocation of hip, open
S83000, Dislocation of patella, closed
S83001, Dislocation of patella, open
S83100, Anterior dislocation of knee, closed
S83101, Anterior dislocation of knee, open
S83110, Posterior dislocation of knee, closed
S83111, Posterior dislocation of knee, open
S83120, Medial dislocation of knee, closed
S83121, Medial dislocation of knee, open
S83130, Lateral dislocation of knee, closed
S83131, Lateral dislocation of knee, open
S83180, Other dislocation of knee, closed
S83181, Other dislocation of knee, open
S83190, Unspeciﬁed dislocation of knee, closed
S83191, Unspeciﬁed dislocation of knee, openReferences
1. Ethgen O, Bruyere O, Richy F, Dardennes C, Reginster J-Y.
Health-related quality of life in total hip and total knee
arthroplasty. A qualitative and systematic review of the liter-
ature. J Bone Joint Surg Am 2004;86-A(5):963e74.
2. Jandric S, Manojlovic S. Quality of life of men and women with
osteoarthritis of the hip and arthroplasty: assessment by
WOMAC questionnaire. Am J Phys Med Rehabil 2009;88(4):
328e35.
3. Jones CA, Beaupre LA, Johnston DWC, Suarez-Almazor ME.
Total joint arthroplasties: current concepts of patient out-
comes after surgery. Rheum Dis Clin North Am 2007;33(1):
71e86.
4. Jones CA, Voaklander DC, Johnston DW, Suarez-Almazor ME.
Health related quality of life outcomes after total hip and knee
B. Ravi et al. / Osteoarthritis and Cartilage 21 (2013) 1841e1848 1847arthroplasties in a community based population. J Rheumatol
2000;27(7):1745e52.
5. Mariconda M, Galasso O, Costa GG, Recano P, Cerbasi S. Quality
of life and functionality after total hip arthroplasty: a long-
term follow-up study. BMC Musculoskelet Disord 2011;12:
222.
6. Montin L, Leino-Kilpi H, Suominen T, Lepisto J. A systematic
review of empirical studies between 1966 and 2005 of patient
outcomes of total hip arthroplasty and related factors. J Clin
Nurs 2008;17(1):40e5.
7. Quintana JM, Escobar A, Arostegui I, Bilbao A, Azkarate J,
Goenaga JI, et al. Health-related quality of life and appropri-
ateness of knee or hip joint replacement. Arch Intern Med
2006;166(2):220e6.
8. Brander VA, Stulberg SD, Adams AD, Harden RN, Bruehl S,
Stanos SP, et al. Predicting total knee replacement pain: a pro-
spective, observational study. Clin Orthop 2003;416:27e36.
9. Hawker GA. Who, when, and why total joint replacement
surgery? The patient’s perspective. Curr Opin Rheumatol
2006;18(5):526e30.
10. Nilsdotter AK, Petersson IF, Roos EM, Lohmander LS. Predictors
of patient relevant outcome after total hip replacement for
osteoarthritis: a prospective study. Ann Rheum Dis
2003;62(10):923e30.
11. Jones CA, Voaklander DC, Johnston DW, Suarez-Almazor ME.
The effect of age on pain, function, and quality of life after
total hip and knee arthroplasty. Arch Intern Med
2001;161(3):454e60.
12. Katz JN, Mahomed NN, Baron JA, Barrett JA, Fossel AH,
Creel AH, et al. Association of hospital and surgeon procedure
volume with patient-centered outcomes of total knee
replacement in a population-based cohort of patients age 65
years and older. Arthritis Rheum 2007;56(2):568e74.
13. Lingard EA, Katz JN, Wright EA, Sledge CB, Kinemax Outcomes
G. Predicting the outcome of total knee arthroplasty. J Bone
Joint Surg Am 2004;86-A(10):2179e86.
14. Mahomed NN, Liang MH, Cook EF, Daltroy LH, Fortin PR,
Fossel AH, et al. The importance of patient expectations in
predicting functional outcomes after total joint arthroplasty.
J Rheumatol 2002;29(6):1273e9.
15. Lingard EA, Berven S, Katz JN, Kinemax Outcomes G. Man-
agement and care of patients undergoing total knee arthro-
plasty: variations across different health care settings. Arthritis
Care Res 2000;13(3):129e36.
16. Lingard EA, Sledge CB, Learmonth ID, Kinemax Outcomes G.
Patient expectations regarding total knee arthroplasty: dif-
ferences among the United States, United kingdom, and
Australia. J Bone Joint Surg Am 2006;88(6):1201e7.
17. Lingard EA, Riddle DL. Impact of psychological distress on pain
and function following knee arthroplasty. J Bone Joint Surg Am
2007;89(6):1161e9.
18. Hawker GA, Badley EM, Croxford R, Coyte PC, Glazier RH,
Guan J, et al. A population-based nested case-control study of
the costs of hip and knee replacement surgery. Med Care
2009;47(7):732e41.
19. Lyman S, Dunn WR, Spock C, Bach PB, Mandl LA, Marx RG.
Validity of same-side reoperation after total hip and knee
arthroplasty using administrative databases. J Knee Surg
2009;22(1):17e20.
20. Paterson JM, Williams JI, Kreder HJ, Mahomed NN, Gunraj N,
Wang X, et al. Provider volumes and early outcomes of pri-
mary total joint replacement in Ontario. Can J Surg
2010;53(3):175e83.
21. Soohoo NF, Zingmond DS, Lieberman JR, Ko CY. Primary
total knee arthroplasty in California 1991 to 2001: doeshospital volume affect outcomes? J Arthroplasty 2006;21(2):
199e205.
22. Felson DT, Naimark A, Anderson J, Kazis L, Castelli W,
Meenan RF. The prevalence of knee osteoarthritis in the
elderly. The Framingham Osteoarthritis Study. Arthritis Rheum
1987;30(8):914e8.
23. Peat G, McCarney R, Croft P. Knee pain and osteoarthritis in
older adults: a review of community burden and current use of
primary health care. Ann Rheum Dis 2001;60(2):91e7.
24. Quintana JM, Arostegui I, Escobar A, Azkarate J, Goenaga JI,
Lafuente I. Prevalence of knee and hip osteoarthritis and the
appropriateness of joint replacement in an older population.
Arch Intern Med 2008;168(14):1576e84.
25. Kurtz SM, Lau E, Ong K, Zhao K, Kelly M, Bozic KJ. Future young
patient demand for primary and revision joint replacement:
national projections from 2010 to 2030. Clin Orthop
2009;467(10):2606e12.
26. Robertsson O, Dunbar MJ, Knutson K, Lidgren L. Past inci-
dence and future demand for knee arthroplasty in Sweden:
a report from the Swedish Knee Arthroplasty Register
regarding the effect of past and future population changes
on the number of arthroplasties performed. Acta Orthop
Scand 2000;71(4):376e80.
27. Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD,
Arden N, et al. OARSI recommendations for the management of
hip and knee osteoarthritis, part II: OARSI evidence-based,
expert consensus guidelines. Osteoarthritis Cartilage
2008;16(2):137e62.
28. Meehan JPDB, Tancredi DJ, Kim S, Jamali AA, White RH.
A population-based comparison of the incidence of adverse
outcomes after simultaneous-bilateral and staged-bilateral
total knee arthroplasty. J Bone Joint Surg Am 2011;93(23):
2203e13.
29. Ko DT, Mamdani M, Alter DA. Lipid-lowering therapy with
statins in high-risk elderly patients: the treatment-risk
paradox. JAMA 2004;291(15):1864e70.
30. Lipscombe LL, Hux JE. Trends in diabetes prevalence, inci-
dence, and mortality in Ontario, Canada 1995e2005: a
population-based study. Lancet 2007;369(9563):750e6.
31. Tu K, Chen Z, Lipscombe LL, Canadian Hypertension Education
Program Outcomes Research T. Prevalence and incidence of
hypertension from 1995 to 2005: a population-based study.
CMAJ 2008;178(11):1429e35.
32. Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al.
Updating and validating the Charlson comorbidity index and
score for risk adjustment in hospital discharge abstracts using
data from 6 countries. Am J Epidemiol 2011;173(6):676e82.
33. Beyersmann J, Gastmeier P, Wolkewitz M, Schumacher M. An
easy mathematical proof showed that time-dependent bias
inevitably leads to biased effect estimation. J Clin Epidemiol
2008;61(12):1216e21.
34. Allison DB, Heo M, Flanders DW, Faith MS, Carpenter KM,
Williamson DF. Simulation study of the effects of excluding
early deaths on risk factor-mortality analyses in the presence
of confounding due to occult disease: the example of body
mass index. Ann Epidemiol 1999;9(2):132e42.
35. Lawlor DA, Hart CL, Hole DJ, Davey Smith G. Reverse causality
and confounding and the associations of overweight and
obesity with mortality. Obesity 2006;14(12):2294e304.
36. Borkhoff CM, Hawker GA, Kreder HJ, Glazier RH, Mahomed NN,
Wright JG. The effect of patients’ sex on physicians’ recom-
mendations for total knee arthroplasty. CMAJ 2008;178(6):
681e7.
37. Borkhoff CM, Hawker GA, Kreder HJ, Glazier RH, Mahomed NN,
Wright JG. Patients’gender affectedphysicians’ clinicaldecisions
B. Ravi et al. / Osteoarthritis and Cartilage 21 (2013) 1841e18481848whenpresentedwithstandardizedpatientsbutnot formatching
paper patients. J Clin Epidemiol 2009;62(5):527e41.
38. Borkhoff CM, Hawker GA, Wright JG. Patient gender affects the
referral and recommendation for total joint arthroplasty. Clin
Orthop 2011;469(7):1829e37.
39. Hawker GA, Wright JG, Coyte PC, Williams JI, Harvey B,
Glazier R, et al. Differences between men and women in the
rate of use of hip and knee arthroplasty. N Engl J Med
2000;342(14):1016e22.
40. Nilsdotter AK, Lohmander LS. Age and waiting time as pre-
dictors of outcome after total hip replacement for osteoar-
thritis. Rheumatology (Oxford) 2002;41(11):1261e7.
41. Santaguida PL, Hawker GA, Hudak PL, Glazier R, Mahomed NN,
Kreder HJ, et al. Patient characteristics affecting the prognosis
of total hip and knee joint arthroplasty: a systematic review.
Can J Surg 2008;51(6):428e36.
42. Bourne RB, Chesworth BM, Davis AM, Mahomed NN,
Charron KDJ. Patient satisfaction after total knee arthroplasty:
who is satisﬁed andwho is not?ClinOrthop 2010;468(1):57e63.43. Papakostidou IDZ, Papapolychroniou T, Liaropoulos L,
Zintzaras E, Karachalios TS, Malizos KN. Factors affecting the
quality of life after total knee arthroplasties: a prospective
study. BMC Musculoskelet Disord 2012;13:116, http://dx.doi.
org/10.1186/1471-2474-13-116.
44. Hawker GA, Guan J, Croxford R, Coyte PC, Glazier RH,
Harvey BJ, et al. A prospective population-based study of the
predictors of undergoing total joint arthroplasty. Arthritis
Rheum 2006;54(10):3212e20.
45. Levesque LE, Hanley JA, Kezouh A, Suissa S. Problem of
immortal time bias in cohort studies: example using statins for
preventing progression of diabetes. BMJ 2010;340:b5087.
46. Dreinhofer KE, Dieppe P, Sturmer T, Grober-Gratz D, Floren M,
Gunther KP, et al. Indications for total hip replacement: com-
parison of assessments of orthopaedic surgeons and referring
physicians. Ann Rheum Dis 2006;65(10):1346e50.
47. Panel NIHC. NIH consensus statement on total knee replace-
ment December 8e10, 2003. J Bone Joint Surg Am 2004;86e
A(6):1328e35.
